SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec inks pact with UNICEF for supply of Pentavalent Vaccine

18 Jan 2017 Evaluate

Panacea Biotec has entered into long term agreement (LTA) with UNICEF for supply of Pentavalent Vaccine (Easyfive-TT) in calendar year 2017 and also received a Notification from Pan American Health Organization (PAHO) for purchase of Pentavalent Vaccine (Easyfive-TT) in the event PAHO should have any requirements through December 31, 2019.

Total value of this expected business from UN Agencies is worth $20.475 million equivalent to around Rs 140 crore based on current exchange rate.

Panacea Biotec is one of the India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

358.00 5.30 (1.50%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×